Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling

Journal of Neuroscience Research

Volumn 70, Issue 3, 2002, Pages 462-473

  Colangelo, Vittorio ^a   Schurr, Jill ^b   Ball, Melvyn J ^c   Pelaez, Ricardo Palacios ^d   Bazan, Nicolas G ^a,e   Lukiw, Walter J ^a,e  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Diater Laboratorios   (Spain)

^e LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid; CDNA array; Cyclooxygenase; Hypoxia; Interleukin 1; Interleukin 1 ; Metal regulatory factor 1; Metallothionein III; Neuroinflammation; Phospholipase A2; Presenilin APP; Transcription factors

Indexed keywords

AMYLOID; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; METAL REGULATORY FACTOR 1; METALLOTHIONEIN; NEUROTROPHIC FACTOR; PHOSPHOLIPASE A2; PRESENILIN 1; PROSTAGLANDIN SYNTHASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CEX1; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DNA MICROARRAY; EXPRESSED SEQUENCE TAG; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; INFLAMMATION; MALE; NERVE CELL PLASTICITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROCESSING; RNA EDITING; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

AGED; ALZHEIMER DISEASE; APOPTOSIS; DNA, COMPLEMENTARY; DOWN-REGULATION; ENCEPHALITIS; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HOMEOSTASIS; HUMANS; MALE; NERVE GROWTH FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0037010289     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10351     Document Type: Article

References (77)

1. Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR. 1995. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde" Clin Anat 8:429-431.
2. Andrews GK. 2001. Cellular zinc sensors: MTF-1 regulation of gene expression. Biometals 14:223-237.
3. Bemaudin M, Nouvelot A, MacKenzie ET, Petit E. 1998. Selective neuronal vulnerability and specific glial reactions in hippocampal and neocortical organotypic cultures submitted to ischemia. Exp Neurol 150:30-39.
4. Blusztajn JK, Berse B. 2000. The cholinergic neuronal phenotype in Alzheimer's disease. Metab Brain Dis 15:45-64.
5. Brennan CM, Steitz JA. 2001. HuR and mRNA stability Cell Mol Life Sci 58:266-277.
6. Brugnera E, Georgiev O, Radtke F, Heuchel R, Baker E, Sutherland GR, Schaffner W. 1994. Cloning, chromosomal mapping and characterization of the human metal-regulatory transcription factor MTF-1. Nucleic Acids Res 22:3167-3173.
7. Butterfield DA, Kanski J. 2001. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev 122:945-962.
8. Butterfield DA, Drake J, Pocernich C, Castegna A. 2001. Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 7:548-554.
9. Chow N, Cox C, Callahan LM, Weimer JM, Guo L, Coleman PD.1998. Expression profiles of multiple genes in single neurons of Alzheimer's disease. Proc Natl Acad Sci USA 95:9620-9625.
10. Christians ES, Yan LJ, Benjamin IJ. 2002. Heat shock factor 1 and heat shock proteins: Critical partners in protection against acute cell injury. Crit Care Med 30(1 Suppl):S43-50.
11. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U. 1985. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132-1139.
12. Czech C, Tremp G, Pradier L. 2000. Presenilins and Alzheimer's disease: Biological functions and pathogenic mechanisms. Prog Neurobiol 60:363-384.
13. Fan XD, Stark GR, Bloom BR. 1989. Molecular cloning of a gene selectively induced by gamma interferon from human macrophage cell line U937. Mol Cell Biol 9:1922-1928.
14. Franceschi C, Valensin S, Lescai F, Olivieri F, Licastro F, Grimaldi LM, Monti D, De Benedictis G, Bonafe M. 2001. Neuroinflammation and the genetics of Alzheimer's disease: The search for a pro-inflammatory phenotype. Aging 13:163-170.
15. Guhaniyogi J, Brewer G. 2001. Regulation of mRNA stability in mammalian cells. Gene 265:11-23.
16. Haskill S, Beg AA, Tompkins SM, Morris JS, Yurochko AD, Sampson-Johannes A, Mondal K, Ralph P, Baldwin AS Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell 65:1281-1289.
17. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF. 1998. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 51:159-162.
18. Hidalgo J, Aschner M, Zatta P, Vasak M. 2001. Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull 55:133-145.
19. Ho L, Pieroni C, Winger D, Purohit DP, Aisen PS, Pasinetti GM. 1999. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J Neurosci Res 57:295-303.
20. Holmes C. 2002. Genotype and phenotype in Alzheimer's disease. Br J Psychiatry 180:131-134.
21. Hromas R, Gray PW, Chantry D, Godiska R, Krathwohl M, Fife K, Bell GI, Takeda J, Aronica S, Gordon M, Cooper S, Broxmeyer HE, Klemsz MJ. 1997. Cloning and characterization of exodus, a novel beta- chemokine. Blood 89:3315-3322.
22. Imaizumi K, Morihara T, Mori Y, Katayama T, Tsuda M, Furuyama T, Wanaka A, Takeda M, Tohyama M. 1999. The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein. J Biol Chem 274:7975-7981.
23. Kaufmann WA, Barnas U, Humpel C, Nowakowski K, DeCol C, Gurka P, Ransmayr G, Hinterhuber H, Winkler H, Marksteiner J. 1998. Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease. Eur J Neurosci 10:1084-1094.
24. Kikuno R, Nagase T, Ishikawa K, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O. 1999. Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones (KIAA1088) from brain which code for large proteins in vitro. DNA Res 6:197-205.
25. Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ, Lees AJ, Marsden CD. 1995. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Mol Brain Res 28:311-318.
26. Kitamura Y, Shimohama S, Koike H, Kakimura J, Matsuoka Y, Nomura Y, Gebicke-Haerter PJ, Taniguchi T. 1999. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains. Biochem Biophys Res Commun 254:582-586.
27. Kril JJ, Patel S, Harding AJ, Halliday GM. 2002. Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation. Acta Neuropathol (Berl) 103:370-306.
28. Lichtlen P, Georgiev O, Schaffner W, Aguzzi A, Brandner S. 1999. The heavy metal-responsive transcription factor-1 (MTF-1) is not required for neural differentiation. J Biol Chem 380:711-715.
29. Liu LX, Lu H, Luo Y, Date T, Belanger AJ, Vincent KA, Akita GY, Goldberg M, Cheng SH, Gregory RJ, Jiang C. 2002. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Biochem Biophys Res Commun 291:908-914.
30. Lukiw WJ. 2001. Aluminum and gene transcription in the mammalian central nervous system. In: Exley C, editor. Aluminum and Alzheimer's Disease, the Science That Describes the Link. New York: Elsevier Press,. p 147-168.
31. Lukiw WJ, Bazan NG. 1997. Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex. J Neurosci Res 50:937-945.
32. Lukiw WJ, Bazan NG. 1998. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J Neurosci Res 53:583-592.
33. Lukiw WJ, Bazan NG. 2000. Neuroinflammatory signaling up-regulation in Alzheimer's disease. Neurochem Res 25:1173-1184.
34. Lukiw WJ, Rogaev EI, Bazan NG. 1996. Synaptic and cytoskeletal RNA message levels in sporadic Alzheimer neocortex. Alzheimer's Res 2:221-227.
35. Lukiw WJ, Carver LA, LeBlanc HJ, Bazan NG. 2000a. Analysis of 1184 gene transcript levels in AD CA1 hippocampus: Synaptic signaling and transcription factor deficits and upregulation of pro-inflammatory pathways. Alzheimer's Rep 3:161-167.
36. Lukiw WJ, Rogaev EI, Bazan NG. 2000b. Potential of transcriptional coordination of nine genes associated with Alzheimer's disease. Alzheimer's Rep 4:233-245.
37. Lukiw WJ, Bazan NG. 2002. COX-2 and PSI gene expression induced by IL-1beta and Abeta42 is potentiated by hypoxia in human primary neural cells. J Biol Chem 277:30359-30367.
38. Martin LJ. 2001. Neuronal cell death in nervous system development, disease, and injury. Int J Mol Med 7:455-478.
39. Mattson MP, Culmsee C, Yu Z, Camandola S. 2000. Roles of nuclear factor kappaB in neuronal survival and plasticity. J Neurochem 74:443-456.
40. McGeer PL, McGeer EG. 1995. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21:195-218.
41. McGeer EG, McGeer PL. 1999. Brain inflammation in Alzheimer disease and the therapeutic implications. Curr Pharm Res 10:821-836.
42. McGeer PL, McGeer EG. 2001a. Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Interleukin-1 and the immunogenetics of Alzheimer disease. J Neuropathol Exp Neurol 59:471-476.
43. McGeer PL, McGeer EG. 2001b. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22:799-809.
44. Morris JC, Price JL. 2001. Pathological correlates of nondemented aging, mild cognitive impairment and early stage Alzheimer's disease. J Molec Neurosci 17:101-118.
45. Mrak RE, Griffin WS. 2000. Interleukin-1 and the immunogenetics of Alzheimer disease. J Neuropathol Exp Neurol 59:471-476.
46. Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. 1999. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 58:1147-1155.
47. Nguyen Ba-Charvet KT, Brose K, Marillat V, Kidd T, Goodman CS Tessier-Lavigne M, Sotelo C, Chedotal, AB.1999. Slit2-Mediated chemorepulsion and collapse of developing forebrain axons. Neuron 22:463-473.
48. Oviedo JA, Wolfe MM. 2001.Clinical potential of cyclo-oxygenase-2 inhibitors. BioDrugs 15:563-572.
49. O'Neil AJ, Kaltschmidt C. 1997. NF-kappa B: A crucial transcription factor for glial and neuronal cell function. Trends Neurol Sci 20:252-258.
50. Price DL, Tanzi RE, Borchelt DR, Sisodia SS. 1998. Alzheimer's disease: Genetic studies and transgenic models. Ann Rev Genet 32:461-493.
51. Rogaev EI, Sherrington R, Wu C, Levesque G, Liang Y, Rogaeva EA, Ikeda M, Holman K, Lin C, Lukiw WJ, de Jong PJ, Fraser PE, Rommens JM, St. George-Hyslop P. 1997. Analysis of the 5′ sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease. Genomics 40:415-424.
52. Rogan S, Lippa CF.2002. Alzheimer's disease and other dementias: A review. Am J Alzheimers Disease and Other Dementias 17:11-17.
53. Rogers J. 1995. Inflammation as a pathogenic mechanism in Alzheimer's disease. Arzneimittelforschung 45:439-442.
54. Rollins BJ, Stier P, Ernst T, Wong GG. 1989. The human homolog of the JE gene encodes a monocyte secretory protein. Mol Cell Biol 9:4687-4695.
55. Ross J. 1996. Control of messenger RNA stability in higher eukaryotes. Trends Genet 5:171-175.
56. Rossler M, Zarski R, Bohl J, Ohm TG. 2002. Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathol (Berl) 103:363-369.
57. Roth SY, Denu JM, Allis CD. 2001.Histone acetyltransferases. Annu Rev Biochem 70:81-120.
58. Ruben SM, Klement JF, Coleman TA, Maher M, Chen CH, Rosen CA. 1992. I-Rel: A novel rel-related protein that inhibits NF-kappa B transcriptional activity. Genes Dev 6:745-760.
59. Sarma V, Wolf FW, Marks RM, Shows TB, Dixit VM. 1992. Cloning of a novel tumor necrosis factor-alpha-inducible primary response gene that is differentially expressed in development and capillary tube-like formation in vitro. J Immunol 148:3302-3312.
60. Sayre LM, Smith MA, Perry G. 2001. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 8:721-738.
61. Scheff SW, Price DA. 1998. Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease J Neuropathol Exp Neurol 57:1146-1153.
62. Shastry BS. 2001. Molecular and cell biological aspects of Alzheimer disease. J Hum Genet 46:609-618.
63. Sterner DE, Berger SL. 2000. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64:435-459.
64. St. George-Hyslop P. 2000. Molecular genetics of Alzheimer's disease Biol Psychiatry 47:183-199.
65. Sutcliffe JG. 2001. Open-system approaches to gene expression in the CNS. J Neurosci 21:8306-8309.
66. Takahashi Y. 1992. Gene expression in cells of the central nervous system. Prog Neurobiol 38:523-569.
67. Tanzi RE, Bertram L. 2001. New frontiers in Alzheimer's disease genetics. Neuron 32:181-184.
68. Thomas EA, Alvarez CE, Sutcliffe JG. 2000. Evolutionarily distinct classes of S27 ribosomal proteins with differential mRNA expression in rat hypothalamus. J Neurochem 74:2259-2267.
69. Tol J, Roks G, Slooter AJ, van Duijn CM. 1999. Genetic and environmental factors in Alzheimer's disease. Rev Neurol 155:10-16.
70. Tsuji T, Shimohama S. 2001. Analysis of the proteomic profiling of brain tissue in Alzheimer's disease. Disease Markers 17:247-257.
71. Van Leeuwen F, Wde Kleijn DP, van den Hurk HH, Neubauer A, Sonnemans MA, Sluijs JA, Koycu S, Ramdjielal RDJ, Salehi A, Martens GJM, Grosveld FG, Peter J, Burbach H, Hol EM. 1998. Frameshift mutants of beta amyloid precursor protein, and ubiquitin-B in Alzheimer's and Down patients. Science 279:242-247.
72. Venter JC, Adams MD, Meyers EW. 2001. The sequence of the human genome. Science 291:1304-51.
73. Wheal HV, Chen Y, Mitchell J, Schachner M, Maerz W, Wieland H, Van Rossum D, Kirsch J. 1998. Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticity. Prog Neurobiol 55:611-640.
74. Yang X, Khosravi-Far R, Chang HY, Baltimore D. 1997. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89:1067-1076.
75. Yao PJ, Morsch R, Callahan LM, Coleman PD. 1999. Changes in synaptic expression of clathrin assembly protein AP180 in Alzheimer's disease analysed by immunohistochemistry. Neuroscience 94:389-394.
76. Yu WH, Lukiw WJ, Bergeron C, Niznik HB, Fraser PE. 2001. Metallothionein III is reduced in Alzheimer's disease. Brain Res 894:37-45.
77. Zhou LJ, Schwarting R, Smith HM, Tedder TF.1992.A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149:735-742.